Regeneron Pharmaceuticals Statistics
Total Valuation
REGN has a market cap or net worth of $96.27 billion. The enterprise value is $80.12 billion.
| Market Cap | 96.27B |
| Enterprise Value | 80.12B |
Important Dates
The last earnings date was Friday, October 30, 2026, before market open.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Nov 20, 2026 |
Share Statistics
REGN has 100.35 million shares outstanding. The number of shares has decreased by -3.11% in one year.
| Current Share Class | 98.53M |
| Shares Outstanding | 100.35M |
| Shares Change (YoY) | -3.11% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 3.80% |
| Owned by Institutions (%) | 93.47% |
| Float | 96.35M |
Valuation Ratios
The trailing PE ratio is 21.24 and the forward PE ratio is 11.93. REGN's PEG ratio is 1.00.
| PE Ratio | 21.24 |
| Forward PE | 11.93 |
| PS Ratio | 5.70 |
| Forward PS | 4.60 |
| PB Ratio | 2.87 |
| P/TBV Ratio | 2.99 |
| P/FCF Ratio | 25.16 |
| P/OCF Ratio | 19.87 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.19, with an EV/FCF ratio of 20.94.
| EV / Earnings | 16.63 |
| EV / Sales | 4.74 |
| EV / EBITDA | 14.19 |
| EV / EBIT | 15.61 |
| EV / FCF | 20.94 |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.35 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.71 |
| Interest Coverage | 109.93 |
Financial Efficiency
Return on equity (ROE) is 14.95% and return on invested capital (ROIC) is 16.31%.
| Return on Equity (ROE) | 14.95% |
| Return on Assets (ROA) | 7.59% |
| Return on Invested Capital (ROIC) | 16.31% |
| Return on Capital Employed (ROCE) | 13.44% |
| Weighted Average Cost of Capital (WACC) | 4.69% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | $313,980 |
| Employee Count | 15,343 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.93 |
Taxes
In the past 12 months, REGN has paid $869.40 million in taxes.
| Income Tax | 869.40M |
| Effective Tax Rate | 15.29% |
Stock Price Statistics
The stock price has increased by +46.53% in the last 52 weeks. The beta is 0.10, so REGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +46.53% |
| 50-Day Moving Average | 811.95 |
| 200-Day Moving Average | 744.87 |
| Relative Strength Index (RSI) | 70.02 |
| Average Volume (20 Days) | 963,395 |
Short Selling Information
The latest short interest is 2.13 million, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 2.13M |
| Short Previous Month | 2.15M |
| Short % of Shares Out | 2.13% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | 2.78 |
Income Statement
In the last 12 months, REGN had revenue of $16.90 billion and earned $4.82 billion in profits. Earnings per share was $45.17.
| Revenue | 16.90B |
| Gross Profit | 7.90B |
| Operating Income | 5.13B |
| Pretax Income | 5.69B |
| Net Income | 4.82B |
| EBITDA | 5.65B |
| EBIT | 5.13B |
| Earnings Per Share (EPS) | $45.17 |
Balance Sheet
The company has $18.86 billion in cash and investments and $2.71 billion in debt, with a net cash position of $16.15 billion or $160.96 per share.
| Cash & Investments | 18.86B |
| Total Debt | 2.71B |
| Net Cash | 16.15B |
| Net Cash Per Share | $160.96 |
| Equity (Book Value) | 33.50B |
| Book Value Per Share | 333.93 |
| Working Capital | 14.59B |
Cash Flow
In the last 12 months, operating cash flow was $4.85 billion and capital expenditures -$1.02 billion, giving a free cash flow of $3.83 billion.
| Operating Cash Flow | 4.85B |
| Capital Expenditures | -1.02B |
| Depreciation & Amortization | 512.90M |
| Net Borrowing | n/a |
| Free Cash Flow | 3.83B |
| FCF Per Share | $38.13 |
Margins
Gross margin is 46.73%, with operating and profit margins of 30.38% and 28.51%.
| Gross Margin | 46.73% |
| Operating Margin | 30.38% |
| Pretax Margin | 33.66% |
| Profit Margin | 28.51% |
| EBITDA Margin | 33.42% |
| EBIT Margin | 30.38% |
| FCF Margin | 22.65% |
Dividends & Yields
This stock pays an annual dividend of $3.76, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | $3.76 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | 6.82% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.32% |
| FCF Payout Ratio | 9.86% |
| Buyback Yield | 3.11% |
| Shareholder Yield | 3.50% |
| Earnings Yield | 4.71% |
| FCF Yield | 3.97% |
Analyst Forecast
The average price target for REGN is $977.93, which is 1.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $977.93 |
| Price Target Difference | 1.93% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 14.85% |
| EPS Growth Forecast (3Y) | 20.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
REGN has an Altman Z-Score of 6.44 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.44 |
| Piotroski F-Score | 6 |